The role of the adenosinergic system in lung fibrosis

被引:40
作者
Della Latta, Veronica [1 ,2 ]
Cabiati, Manuela [1 ]
Rocchiccioli, Silvia [1 ]
Del Ry, Silvia [1 ]
Morales, Maria-Aurora [1 ]
机构
[1] CNR, Inst Clin Physiol, I-56126 Pisa, Italy
[2] Univ Siena, I-53100 Siena, Italy
关键词
Adenosine; Adenosine receptors; Lung disease; Idiopathic pulmonary fibrosis; Bleomycin; IDIOPATHIC PULMONARY-FIBROSIS; RECEPTOR; MECHANISMS; INFLAMMATION; PATHOGENESIS; EXPRESSION; PROGRESS; DISEASE; TARGETS; MODELS;
D O I
10.1016/j.phrs.2013.08.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine (ADO) is a retaliatory metabolite that is expressed in conditions of injury or stress. During these conditions ATP is released at the extracellular level and is metabolized to adenosine. For this reason, adenosine is defined as a "danger signal" for cells and organs, in addition to its important role as homeostatic regulator. Its physiological functions are mediated through interaction with four specific transmembrane receptors called ADORA1, ADORA2A, ADORA2B and ADORA3. In the lungs of mice and humans all four adenosine receptors are expressed with different roles, having pro- and anti-inflammatory roles, determining bronchoconstriction and regulating lung inflammation and airway remodeling. Adenosine receptors can also promote differentiation of lung fibroblasts into myofibroblasts, typical of the fibrotic event. This last function suggests a potential involvement of adenosine in the fibrotic lung disease processes, which are characterized by different degrees of inflammation and fibrosis. Idiopathic pulmonary fibrosis (IPF) is the pathology with the highest degree of fibrosis and is of unknown etiology and burdened by lack of effective treatments in humans. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:182 / 189
页数:8
相关论文
共 67 条
[1]  
Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646
[2]   Pharmacological modulation of adenosine system: Novel options for treatment of inflammatory bowel diseases [J].
Antonioli, Luca ;
Fornai, Motteo ;
Colucci, Rocchina ;
Ghisu, Narcisa ;
Tuccori, Marco ;
Del Tacca, Mario ;
Blandizzi, Corrado .
INFLAMMATORY BOWEL DISEASES, 2008, 14 (04) :566-574
[3]   Fibrogenic Reactions in Lung Disease [J].
Araya, Jun ;
Nishimura, Stephen L. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2010, 5 :77-98
[4]   The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis [J].
Barbarin, V ;
Nihoul, A ;
Misson, P ;
Arras, M ;
Delos, M ;
Leclercq, I ;
Lison, D ;
Huaux, F .
RESPIRATORY RESEARCH, 2005, 6 (1)
[5]   Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A multicenter case-control study [J].
Baumgartner, KB ;
Samet, JM ;
Coultas, DB ;
Stidley, CA ;
Hunt, WC ;
Colby, TV ;
Waldron, JA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (04) :307-315
[6]   Purine and pyrimidine receptors [J].
Burnstock, G. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (12) :1471-1483
[7]   Purinergic Signaling in the Airways [J].
Burnstock, Geoffrey ;
Brouns, Inge ;
Adriaensen, Dirk ;
Timmermans, Jean-Pierre .
PHARMACOLOGICAL REVIEWS, 2012, 64 (04) :834-868
[8]   Adenosine signalling in airways [J].
Caruso, Massimo ;
Holgate, Stephen T. ;
Polosa, Riccardo .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (03) :251-256
[9]   Adenosine signaling pathways as potential therapeutic targets in respiratory disease [J].
Caruso, Massimo ;
Alamo, Angela ;
Crisafulli, Emanuele ;
Raciti, Cirino ;
Fisichella, Alfredo ;
Polosa, Riccardo .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) :761-772
[10]   Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent [J].
Christensen, PJ ;
Goodman, RE ;
Pastoriza, L ;
Moore, B ;
Toews, GB .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (05) :1773-1779